英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
metipranolol |
美替洛爾 |
22664-55-7 |
詳細(xì)
|
AZD-7648 |
AZD-7648 |
2230820-11-6 |
詳細(xì)
|
(S)-5-hydroxy-3-(2-(((1-((1-methyl-1H-imidazol-4-yl)methyl)-1H-indol-6-yl)methylamino)methyl)-1H-indol-3-yl)isoindolin-1-one |
(S)-5-hydroxy-3-(2-(((1-((1-methyl-1H-imidazol-4-yl)methyl)-1H-indol-6-yl)methylamino)methyl)-1H-indol-3-yl)isoindolin-1-one |
2375482-51-0 |
詳細(xì)
|
1-[(5-CHLORO-1H-BENZIMIDAZOL-2-YL)CARBONYL]-4-METHYLPIPERAZINE MALEATE |
1-[(5-CHLORO-1H-BENZIMIDAZOL-2-YL)CARBONYL]-4-METHYLPIPERAZINE MALEATE |
869497-75-6 |
詳細(xì)
|
MK-0941 |
MK-0941 |
1137916-97-2 |
詳細(xì)
|
Batefenterol |
BATEFENTEROL |
743461-65-6 |
詳細(xì)
|
Mirogabalin besylate |
10928苯磺酸鹽 |
1138245-21-2 |
詳細(xì)
|
N-{(1S,2R)-1-benzyl-3-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-hydroxy-3-oxopropyl}-5-chloro-1H-indole-2-carboxaMide|ingliforib |
CPD2802 |
186392-65-4 |
詳細(xì)
|
CPD1815 |
CPD1815 |
2166387-64-8 |
詳細(xì)
|
BLU-285 |
阿伐普替尼 |
1703793-34-3 |
詳細(xì)
|
3-(3-(((4-((Dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindolin-6-yl)-N-ethylpropiolamide |
BI-847325 |
1207293-36-4 |
詳細(xì)
|
Bardoxolone |
2-氰基-3,12-二氧代齊墩果-1,9-二烯-28-酸 |
218600-44-3 |
詳細(xì)
|
AZD5069 |
AZD5069 |
878385-84-3 |
詳細(xì)
|
IPI-549 |
IPI-549 |
1693758-51-8 |
詳細(xì)
|
CPDD0945 |
CPDD0945 |
1632118-69-4 |
詳細(xì)
|
5H-Imidazo[5,1-a]isoindole-5-ethanol, α-cyclohexyl- |
1-環(huán)己基-2-(5H-咪唑并[5,1-A]異吲哚-5-基)乙醇 |
1402836-58-1 |
詳細(xì)
|
N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline |
EW-7197 |
1352608-82-2 |
詳細(xì)
|
7-(5-Methyl-2-furanyl)-3-[[6-[[[(3S)-tetrahydro-3-furanyl]oxy]methyl]-2-pyridinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine |
CPI-444 |
1202402-40-1 |
詳細(xì)
|
1-Methylethyl 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indol-3-yl)-5-pyrimidinecarboxylate |
莫博替尼 |
1847461-43-1 |
詳細(xì)
|
EED226 |
EED226 |
2083627-02-3 |
詳細(xì)
|
NVP-BGJ398 |
FGFR抑制劑(NVP-BGJ398) |
872511-34-7 |
詳細(xì)
|
Derazantinib |
德拉贊替尼 |
1234356-69-4 |
詳細(xì)
|
Olodaterol |
奧達(dá)特羅 |
868049-49-4 |
詳細(xì)
|
Tropifexor |
Tropifexor |
1383816-29-2 |
詳細(xì)
|
H3B-6527 |
H3B-6527 |
1702259-66-2 |
詳細(xì)
|
GLPG0187 |
GLPG0187, 一種廣譜的INTEGRIN受體拮抗劑,具有抗腫瘤活性 |
1320346-97-1 |
詳細(xì)
|
1-((S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl)-3-((S)-1-(thiophen-3-yl)propan-2-yl)urea |
PZM-21 |
1997387-43-5 |
詳細(xì)
|
2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl- |
瑞格非尼 |
755037-03-7 |
詳細(xì)
|
R788(Fostamatinib disodium) |
R788(FOSTAMATINIB DISODIUM) |
1025687-58-4 |
詳細(xì)
|
GSK2256098 |
GSK-2256098 |
1224887-10-8 |
詳細(xì)
|
A-966492 |
A-966492 |
934162-61-5 |
詳細(xì)
|
AZD8931 |
AZD8931 |
848942-61-0 |
詳細(xì)
|
Acetic acid, 2-[[4-[(1S)-1-[[(4,5-dichloro-1,6-dimethyl-1H-indol-2-yl)carbonyl]amino]-2-hydroxyethyl]phenyl]sulfonyl]- |
Acetic acid, 2-[[4-[(1S)-1-[[(4,5-dichloro-1,6-dimethyl-1H-indol-2-yl)carbonyl]amino]-2-hydroxyethyl]phenyl]sulfonyl]- |
2244452-09-1 |
詳細(xì)
|
PI3K-IN-2 |
PI3K/MTOR抑制劑 |
1225037-39-7 |
詳細(xì)
|
Nrf1-activator-1 |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
詳細(xì)
|
4-Piperidinecarboxylic acid, 1-(2,3-dichlorobenzoyl)-4-[[5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]- |
化合物 T34787 |
1453099-83-6 |
詳細(xì)
|
Thieno[2,3-d]pyrimidine-3(2H)-acetic acid, 6-bromo-1,4-dihydro-α,α,5-trimethyl-2,4-dioxo-, 1,1-dimethylethyl ester |
Thieno[2,3-d]pyrimidine-3(2H)-acetic acid, 6-bromo-1,4-dihydro-偽,偽,5-trimethyl-2,4-dioxo-, 1,1-dimethylethyl ester |
1434643-33-0 |
詳細(xì)
|
RTA dh404 |
RTA dh404 |
1191265-33-4 |
詳細(xì)
|
3-Pyrrolidinecarboxylic acid, 1-[[7-cyano-2-[3'-[[3-[[(3R)-3-hydroxy-1-pyrrolidinyl]methyl]-1,7-naphthyridin-8-yl]amino]-2,2'-dimethyl[1,1'-biphenyl]-3-yl]-5-benzoxazolyl]methyl]-, (3R)- |
INCB084550 |
2230911-59-6 |
詳細(xì)
|
BDTX-189 |
BDTX-189 |
2414572-47-5 |
詳細(xì)
|
Lazertinib |
YH-25448 |
1903008-80-9 |
詳細(xì)
|
Parsaclisib |
化合物PARSACLISIB |
1426698-88-5 |
詳細(xì)
|
ITF2357 |
N-[4-[(羥基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯鹽酸鹽水合物 |
732302-99-7 |
詳細(xì)
|
7-(BENZOYLAMINO)-4,9-DIHYDRO-4-METHYL-9-OXO-PYRAZOLO[5,1-B]QUIZOLINE-2-CARBOXYLIC ACID |
7-(BENZOYLAMINO)-4,9-DIHYDRO-4-METHYL-9-OXO-PYRAZOLO[5,1-B]QUINAZOLINE-2-CARBOXYLIC ACID |
77422-99-2 |
詳細(xì)
|
1,6-Naphthyridine-6(5H)-carboxamide, N-[2-(4-fluorophenoxy)-5-pyrimidinyl]-5-(4-fluorophenyl)-7,8-dihydro-, (5S)- |
化合物 T10476 |
2471967-92-5 |
詳細(xì)
|
ART558 |
化合物ART558 |
2603528-97-6 |
詳細(xì)
|
IPN-60090 |
IPN-60090 |
1853164-83-6 |
詳細(xì)
|
4-Cyano-N-(1,2-dihydro-1,3-dimethyl-2-oxo-6-quinolinyl)benzenesulfonamide |
NI-42 |
1884640-99-6 |
詳細(xì)
|
CPD1640 |
BMS-986195 |
1912445-55-6 |
詳細(xì)
|
Galloflavin |
培黃素 |
568-80-9 |
詳細(xì)
|
DGAT-1 inhibitor |
DGAT-1 抑制劑 |
959122-11-3 |
詳細(xì)
|
Tetrazolo[1,5-a]pyrimidine-6-carboxamide, 4,7-dihydro-4,5,7,7-tetramethyl-N-(3-phenyl-1H-indazol-5-yl)- |
化合物EB-42486 |
2390475-81-5 |
詳細(xì)
|
2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]- |
2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]- |
1370363-74-8 |
詳細(xì)
|
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide |
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide |
1030203-81-6 |
詳細(xì)
|
Imidazole ketone erastin (PUN30119) |
沒(méi)找到 |
1801530-11-9 |
詳細(xì)
|
BI 2536 |
BI 2536 |
755038-02-9 |
詳細(xì)
|
(2S)-1-(3-Azabicyclo[3.1.0]hex-3-ylcarbonyl)-N-(2-cyclopropylethyl)-2,3,4,5-tetrahydro-2-methyl-4-oxo-1H-1,5-benzodiazepine-7-carboxamide |
BAY-6035 |
2247890-13-5 |
詳細(xì)
|
CP 94253 hydrochloride |
CP 94253鹽酸鹽 |
845861-39-4 |
詳細(xì)
|
DS-7423 |
DS 7423) |
1222104-37-1 |
詳細(xì)
|
1H-Pyrrole-2-carboxamide, 1-(4-pyridinylmethyl)-N-[4-[(2R)-1-(2-pyridinyl)-2-pyrrolidinyl]-2-thiazolyl]- |
化合物SEC61-IN-1 |
2484865-42-9 |
詳細(xì)
|
4-Thiazoleacetamide, 2-[(6-methyl-2-pyridinyl)amino]-N-(5-methyl-2-thiazolyl)- |
HQ461 |
1226443-41-9 |
詳細(xì)
|
Unii-2W150K0uuc |
Odevixibat |
501692-44-0 |
詳細(xì)
|
Benzamide, N-[5-(3,5-dicyano-1,4-dihydro-1,2,6-trimethyl-4-pyridinyl)-6-fluoro-7-methyl-1H-indazol-3-yl]-2-ethyl- |
BAY-3827 |
2377576-35-5 |
詳細(xì)
|
KW-2478 |
KW-2478 |
819812-04-9 |
詳細(xì)
|
2-((S)-1-acryloyl-4-(7-(8-methylnaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-2-yl)acetonitrile |
MRTX-1257 |
2206736-04-9 |
詳細(xì)
|
Pemigatinib |
培米加替尼 |
1513857-77-6 |
詳細(xì)
|
Pirtobrutinib |
LOXO-305 |
2101700-15-4 |
詳細(xì)
|
SC-43 |
SC-43 |
1400989-25-4 |
詳細(xì)
|
VR23 |
VR23 |
1624602-30-7 |
詳細(xì)
|
SGI 7079 |
3-[2-[[3-氟-4-(4-甲基-1-哌嗪基)苯基]氨基]-5-甲基-7H-吡咯并[2,3-D]嘧啶-4-基]苯乙腈 |
1239875-86-5 |
詳細(xì)
|
FIIN-3 |
FIIN-3 |
1637735-84-2 |
詳細(xì)
|
EBI-2511 |
化合物EBI-2511 |
2098546-05-3 |
詳細(xì)
|
4-Piperidinone, 3,5-bis[(4-methylphenyl)methylene]-, hydrochloride (1:1) |
NSC632839hydrochloride |
157654-67-6 |
詳細(xì)
|
NSC 348884 |
N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺 |
81624-55-7 |
詳細(xì)
|
Everolimus |
依維莫司 |
159351-69-6 |
詳細(xì)
|
Wnt-C59 |
PORCN酶活性和WNT抑制劑(WNT-C59) |
1243243-89-1 |
詳細(xì)
|
Romidepsin |
羅米地辛 |
128517-07-7 |
詳細(xì)
|
Ceralasertib |
AZD6738 |
1352226-88-0 |
詳細(xì)
|
DAPT (GSI-IX, LY-374973) |
DAPT |
208255-80-5 |
詳細(xì)
|
GSK126 |
GSK126 |
1346574-57-9 |
詳細(xì)
|
Trichostatin A |
曲古柳菌素A |
58880-19-6 |
詳細(xì)
|
Q-VD-OPh |
(3S)-5-(2,6-二氟苯氧基)-3-[[(2S)-3-甲基-1-氧代-2-[(2-喹啉甲?;?氨基]丁基]氨基]-4-氧代-戊酸 |
1135695-98-5 |
詳細(xì)
|
(-)-Blebbistatin |
(-)-BLEBBISTATIN |
856925-71-8 |
詳細(xì)
|
Bucladesine sodium |
二丁酰環(huán)磷腺甙 |
16980-89-5 |
詳細(xì)
|
Pevonedistat |
氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氫-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羥基環(huán)戊基]甲基酯 |
905579-51-3 |
詳細(xì)
|
(R)-GNE-140 |
(R)-GNE-140 |
2003234-63-5 |
詳細(xì)
|
Ulixertinib |
4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羥基乙基]-1H-吡咯-2-甲酰胺 |
869886-67-9 |
詳細(xì)
|
LGK974 |
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-聯(lián)吡啶]-5-乙酰胺 |
1243244-14-5 |
詳細(xì)
|
3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)- |
3-去氮腺嘌呤A |
120964-45-6 |
詳細(xì)
|
Bleomycin sulfate |
硫酸博萊霉素 |
9041-93-4 |
詳細(xì)
|
Bafilomycin A1 |
巴佛洛霉素 A1 |
88899-55-2 |
詳細(xì)
|
Laduviglusib monohydrochloride |
CHIR-99021鹽酸鹽 |
1797989-42-4 |
詳細(xì)
|
Z-VAD(OMe)-FMK |
氟甲基酮 |
187389-52-2 |
詳細(xì)
|
Adenosine,3'-[[(2S)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyl-, dihydrochloride |
嘌呤霉素二鹽酸鹽水合物 |
58-58-2 |
詳細(xì)
|
Poly(ethylene glycol) |
聚乙二醇 |
25322-68-3 |
詳細(xì)
|
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine |
吉非替尼 |
184475-35-2 |
詳細(xì)
|
STM2457 |
STM2457 |
2499663-01-1 |
詳細(xì)
|
6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one hydrochloride |
帕布昔利布鹽酸鹽 |
827022-32-2 |
詳細(xì)
|
(5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one |
依托泊苷 |
33419-42-0 |
詳細(xì)
|
Trans-L-Diaminocyclohexane Oxalatoplatinum |
奧沙利鉑 |
61825-94-3 |
詳細(xì)
|